Zymar and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zymar (gatifloxacin) and Oxycodone (oxycodone hydrochloride). Common drug interactions include loss of consciousness among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Zymar and Oxycodone. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Zymar?

Zymar has active ingredients of gatifloxacin. eHealthMe is studying from 692 Zymar users. Check the latest studies of Zymar.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

On Jul, 20, 2026

25 people who take Zymar and Oxycodone together, and have interactions are studied.

What are the common drug interactions of Zymar and Oxycodone, by gender? *:

female:

Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Chronic kidney disease
Renal failure (kidney dysfunction)
Nephrogenic anaemia (anaemia due to kidney disease)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Joint range of motion decreased (disease of joint movement)
Abdominal pain

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Psychological trauma
Gait disturbance
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Pain in extremity
Arteriosclerosis (thickening and hardening of arteries)
Bankruptcy
Drug dependence

What are the common drug interactions of Zymar and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

30-39:

n/a

40-49:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Gait disturbance
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephropathy (damage to or disease of a kidney)
Pain in extremity

50-59:

Chronic kidney disease

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Altered state of consciousness (altered state of mind)
Anaemia (lack of blood)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
Aphasia (damage to the parts of the brain that control language)
Arteriosclerosis (thickening and hardening of arteries)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 64.00%
High Blood Pressure: 14 people, 56.00%
High Blood Cholesterol: 12 people, 48.00%
Infection: 9 people, 36.00%
Cardiac Disorder: 6 people, 24.00%
Chest Pain: 6 people, 24.00%
Nausea (feeling of having an urge to vomit): 5 people, 20.00%
Headache (pain in head): 5 people, 20.00%
Diabetes: 5 people, 20.00%
Indigestion: 5 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zymar and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously